Neuropharmagen® is a breakthrough in pharmacogenetics that helps to identify the safest and most appropriate psychotropic medication for each patient, by analyzing their DNA. It provides the most extensive genetic-based information on drug efficacy, metabolism and adverse effects.
Neuropharmagen® helps reduce the time spent searching for the most effective treatment choices unique to each patient. This allows for a faster stabilization of patients and better quality of life..

How does it work?

Neuropharmagen® testing is carried out on a saliva sample:

  • DNA markers of efficacy, optimal dosage and adverse effects are analyzed.
  • A series of specific recommendations are provided based on the test results, to help the physician choose the most appropriate choices for each patient.
Psychiatrist at Ramon y Cajal Hospital, Madrid
The intention to change treatment after a detailed analysis of the results, happened in 57% the patients studied. We also identified many patients in our sample who had at least a better treatment choice within the same therapeutic group: 81% were receiving suboptimal treatment, or had at least a probably better treatment option. Identifying these parameters and knowing that there may be a better alternative at the beginning of...
More info
True success stories
GAD / aged 50

GAD is a 50 year-old woman who has resistant depression and responds poorly to treatment, with poor metabolism of the various drugs that she has tried up to now.
Her psychiatrist recommended her to take the Neuropharmagen test and the results led to improved treatment by identifying the most suitable drugs for her particular genetic profile: in this case, dosages of Citalopram and Topiramate were adjusted.
More info
You can contact us here
I have read and accept AB Biotics, Inc.’s Personal Data Protection Policy
you call
Leave your phone and contact you
I have read and accept AB Biotics, Inc.’s Personal Data Protection Policy